Overview A Phase 2 Study of 6MW3211 in Patients With Advanced Clear Cell Renal Cancer Status: Not yet recruiting Trial end date: 2024-09-01 Target enrollment: Participant gender: Summary single arm, non-randomized, multicenter, open label, phase 2 clinical trial in patients with advanced clear cell renal cacer Phase: Phase 2 Details Lead Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.